Related Experiment Video
Updated: Jun 13, 2026

Quantitation of Protein Expression and Co-localization Using Multiplexed Immuno-histochemical Staining and Multispectral Imaging
Published on: April 8, 2016
Head-to-head Comparison of Multimodal Imaging for Prostate Cancer Detection and Local Staging with Whole-mount
Qi Miao1, Anthony Sisk2, Ida Sonni3
1Department of Radiological Sciences, David Geffen School of Medicine, University of California, Los Angeles, Los Angeles, CA, USA; Department of Radiology, The First Hospital of China Medical University, Shenyang, Liaoning, China.
Microultrasound (microUS) showed comparable performance to multiparametric magnetic resonance imaging (mpMRI) and prostate-specific membrane antigen positron emission tomography/computed tomography (PSMA PET/CT) for detecting prostate cancer (PCa). This suggests microUS may serve as a valuable alternative in certain clinical scenarios.
Area of Science:
- Oncology
- Radiology
- Medical Imaging
Background:
- Accurate prostate cancer (PCa) detection and staging are crucial for treatment planning.
- Limited head-to-head comparisons exist for advanced PCa imaging modalities.
Purpose of the Study:
- To compare microultrasound (microUS), multiparametric magnetic resonance imaging (mpMRI), and PSMA PET/CT for detecting clinically significant PCa (csPCa) and extraprostatic extension (EPE).
- To establish whole-mount histopathology (WMHP) as the reference standard for comparison.
Main Methods:
- Retrospective analysis of patients undergoing microUS and mpMRI prior to radical prostatectomy.
- Inclusion of a subset of patients who also underwent PSMA PET/CT.
- Assessment of csPCa and EPE detection rates and positive predictive values (PPVs) using WMHP, with statistical comparisons via McNemar and chi-square tests.
Main Results:
- No significant differences in index lesion or csPCa detection rates were found between microUS, mpMRI, and PSMA PET/CT.
- mpMRI demonstrated higher PPVs for csPCa detection compared to microUS (0.91 vs. 0.77).
- mpMRI achieved the highest sector-level AUCs for csPCa (0.73) and EPE (0.88).
- 15-18% of csPCa lesions were missed across all modalities, primarily smaller, non-index lesions.
Conclusions:
- MicroUS performance is comparable to mpMRI and PSMA PET/CT for detecting index and csPCa lesions.
- MicroUS may play a complementary role in resource-limited settings or for patients with MRI contraindications.
- Further research may be needed to clarify subtle differences and optimize modality selection.
More Related Videos
07:34Enhancing Prostate Tumor Biobanking Reliability with Improved Sampling Technique and Histological Characterization
Published on: November 17, 2023
06:08A Cognitive Fusion-guided Prostate Biopsy Using Multiparametric Magnetic Resonance Imaging and Transrectal Ultrasound
Published on: March 21, 2025